A Study to Characterize the Prevalence of Overweight and Obesity Among Patients With Established Cardiovascular Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5360 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-06-12

Study Completion Date

2024-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this observational study is to measure how many people are overweight or obese amongst patients with a diagnosed cardiovascular disease (CVD). The study also aims to characterise the population including the presence of cardiovascular (CV) risk factors in a number of countries across the globe representing different geographies, ethnicities, as well as different healthcare systems.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi Arabia

NCT05642533

Obesity and Cardiovascular Risk

COMPLETED

Obesity: an Underappreciate Risk Factor for Severe Form of COVID-19

NCT05771857

COVID-19 Pandemic Obesity

COMPLETED

Cardiometabolic Risk of Obese Subjects: Cross-sectional Study

NCT06714058

Obesity and Obesity-related Medical Conditions Cardiovascular Risk Genetics

RECRUITING

New Body Mass Index (BMI) Cut-offs for the Diagnosis of Obesity and Comorbidities

NCT01055626

Obesity Overweight Diabetes Mellitus, Type 2

UNKNOWN

Primary Prevention Study: Study on Obesity, Cardiovascular and Psycho-Social Characteristics in the City of Merzig

NCT00111059

Obesity Cardiovascular Disease Depression +1 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Overweight

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

People with established CVD

Adults diagnosed with established CVD, attending routine medical care or follow-up in a cardiology clinic.

No treatment given

Intervention Type OTHER

No treatment given

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No treatment given

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
2. Adults, age above or equal to 18 years at the time of signing informed consent.
3. Have established CVD and equal to or greater than 1 follow up appointment following an acute event from at least one of the following:

* Prior myocardial infarction
* Prior stroke (ischemic or haemorrhagic stroke)
* Symptomatic peripheral arterial disease (PAD), as evidenced by intermittent claudication with ankle-brachial index (ABI) below 85 (at rest), or peripheral arterial revascularization procedure, or amputation due to atherosclerotic disease

Exclusion Criteria

1. Previous participation in this study. Participation is defined as having given informed consent in this study
2. Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
3. Patients with known congenital heart disease/malformation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No